Rising drug prices drive US manufacturers’ revenues, analysis finds

BMJ 2015; 351 doi: (Published 07 October 2015) Cite this as: BMJ 2015;351:h5376
  1. Michael McCarthy
  1. 1Seattle

Drug price rises are contributing three times more to US drug company revenues than are increases in the volume of their prescription sales, shows an analysis of corporate filings and industry data conducted by the Wall Street Journal.

The analysis,1 reported on 5 October by the newspaper’s biotechnology reporter, Joseph Walker, found that wholesale price increases among the 30 top selling drugs sold by pharmacies in the United States averaged …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to to receive unlimited access to all content on for 14 days.
Sign up for a free trial